Top Markets
Coin of the day
Xeno Transplants Corporation Xeno Transplants Corporation

Xeno Transplants Corporation

XENO
Rang în acțiuni #42146
Xeno Transplants Corporation functions as a biotechnology firm dedicated to... Xeno Transplants Corporation functions as a biotechnology firm dedicated to research and development. Leveraging a specific licensing agreement with Massachusetts General Hospital, the company aims to innovate, produce, commercialize, and implement products and methodologies for public application in the field of xenotransplantation. The primary objective of this xenotransplantation research is to alleviate the critical scarcity of human cells, tissues, and organs required for medical transplants. This is achieved by pioneering techniques that enable the transfer of biological components—such as cells, tissues, and organs—from non-human species, including pigs, into human recipients. Established in 2004, Xeno Transplants Corporation maintains its headquarters in Brookline, Massachusetts.
Preț acțiune
$0.0001
Ultima sincronizare: 2026-08-11
Capitalizare de piață
$4.04K
Schimbare (1 zi)
0.00%
Schimbare (1 an)
0.00%
Țară
CA
Tranzacționează Xeno Transplants Corporation (XENO)

Categorie

Raport P/S pentru Xeno Transplants Corporation (XENO)
Raport P/S la data de 2026 TTM: 0
Conform celor mai recente rapoarte financiare și prețului acțiunilor Xeno Transplants Corporation, raportul P/S actual (TTM) este 0. La sfârșitul anului 2026, compania avea un P/S de 0.
Istoricul raportului P/S pentru Xeno Transplants Corporation din 2026 până în 2026
Raport P/S la sfârșitul fiecărui an
An Raport P/S Schimbă
Nu sunt suficiente date pentru perioada selectată.
Raport P/S pentru companii similare sau competitoare
Companie Raport P/S Diferență raport P/S Țara
9.88 -
US
10.30 -
NL
- -
CH
4.98 -
BE
- -
KR